JNJ

224.16

-1.45%↓

UNH

370.76

+0.47%↑

TMO

462.35

-1.48%↓

ISRG

452.39

-1.14%↓

ABT

87.56

-2.18%↓

JNJ

224.16

-1.45%↓

UNH

370.76

+0.47%↑

TMO

462.35

-1.48%↓

ISRG

452.39

-1.14%↓

ABT

87.56

-2.18%↓

JNJ

224.16

-1.45%↓

UNH

370.76

+0.47%↑

TMO

462.35

-1.48%↓

ISRG

452.39

-1.14%↓

ABT

87.56

-2.18%↓

JNJ

224.16

-1.45%↓

UNH

370.76

+0.47%↑

TMO

462.35

-1.48%↓

ISRG

452.39

-1.14%↓

ABT

87.56

-2.18%↓

JNJ

224.16

-1.45%↓

UNH

370.76

+0.47%↑

TMO

462.35

-1.48%↓

ISRG

452.39

-1.14%↓

ABT

87.56

-2.18%↓

Home・Aandelen Lijst・NeoGenomics Inc

NeoGenomics Inc

Gesloten

8.99 -4.87

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

8.99

Max

9.65

Belangrijke statistieken
By Trading Economics
Inkomsten	17M -9.9M
Verkoop	2.4M 190M
Winstmarge	-5.196
Werknemers	2,500
EBITDA	15M 5.3M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+58.26% upside

Dividenden
By Dow Jones
Volgende Winsten	28 jul 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-352M 1.1B
Vorige openingsprijs	13.86
Vorige sluitingsprijs	8.99

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

7.7 / 10.27 Steun & Weerstand

NeoGenomics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

4 mei 2026, 18:18 UTC

Marktinformatie

Bitcoin Pushes Over $80k as Oil-BTC Relationship Steps Aside -- Market Talk

4 mei 2026, 14:38 UTC

Marktinformatie

Bitcoin Stuck Between Narratives -- Market Talk

4 mei 2026, 14:21 UTC

Marktinformatie

Bitcoin Below $80k Resistance -- Market Talk

1 mei 2026, 19:33 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

1 mei 2026, 19:33 UTC

Marktinformatie

Change in Fed Leadership May Hamper Crypto Rebound -- Market Talk

1 mei 2026, 17:37 UTC

Marktinformatie

Crypto 'Fear and Greed Index' Returns to Neutral Reading After Brief Dip -- Market Talk

1 mei 2026, 16:38 UTC

Marktinformatie

Institutional Markets Begin to Trade on Event Contracts -- Market Talk

1 mei 2026, 16:20 UTC

Marktinformatie

Financial Services Roundup: Market Talk

1 mei 2026, 15:43 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

1 mei 2026, 15:43 UTC

Marktinformatie

Correlation Between Bitcoin and Equities Seen Loosening -- Market Talk

1 mei 2026, 15:43 UTC

Marktinformatie

Global Equities Roundup: Market Talk

1 mei 2026, 11:40 UTC

Marktinformatie

Bitcoin Rises as U.S. Stock Futures Point to Further Gains -- Market Talk

1 mei 2026, 07:09 UTC

Marktinformatie

Winsten

Bitcoin Rises After Gains on Wall Street -- Market Talk

30 apr 2026, 18:00 UTC

Marktinformatie

Cryptocurrency Rebounds After Fed Holds Rates Steady -- Market Talk

30 apr 2026, 13:47 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

30 apr 2026, 13:47 UTC

Marktinformatie

Bitcoin Rises But Iran War Uncertainty Keeps Gains Limited -- Market Talk

30 apr 2026, 07:02 UTC

Marktinformatie

Winsten

Global Equities Roundup: Market Talk

30 apr 2026, 07:02 UTC

Marktinformatie

Winsten

Global Energy Roundup: Market Talk

30 apr 2026, 07:02 UTC

Marktinformatie

Winsten

Bitcoin Recovers Slightly as Trades Weigh Tech Earnings, Iran War News -- Market Talk

29 apr 2026, 18:15 UTC

Marktinformatie

Cryptocurrency Down Following Fed Decision -- Market Talk

29 apr 2026, 17:25 UTC

Winsten

Robinhood Stock Falls After Earnings Fall Short. Blame the Crypto Slump. -- Barrons.com

29 apr 2026, 13:58 UTC

Marktinformatie

Cryptocurrencies Turn Higher as Market Awaits Fed -- Market Talk

29 apr 2026, 11:18 UTC

Marktinformatie

Bitcoin Rises Modestly as U.S. Stock Futures Rise -- Market Talk

29 apr 2026, 09:32 UTC

Winsten

Robinhood Stock Falls After Earnings Fall Short. Blame the Crypto Slump. -- Barrons.com

29 apr 2026, 07:22 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Global Energy Roundup: Market Talk

29 apr 2026, 07:22 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Bitcoin Edges Higher But Iran War Uncertainties Limit Gains -- Market Talk

28 apr 2026, 22:51 UTC

Winsten

Robinhood Earnings Fall Short. A Crypto Slump Is the Culprit. -- Barrons.com

28 apr 2026, 20:51 UTC

Winsten

Robinhood Earnings Fall Short. A Crypto Slump Is the Culprit. -- Barrons.com

28 apr 2026, 20:24 UTC

Winsten

Robinhood Earnings Fall Short. A Crypto Slump Is the Culprit. -- Barrons.com

28 apr 2026, 17:24 UTC

Marktinformatie

Bitcoin Stabilizes Around $76k After ETF Inflow Streak Ends -- Market Talk

Peer Vergelijking

Prijswijziging

NeoGenomics Inc Prognose

Koersdoel

By TipRanks

58.26% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 14.94 USD 58.26%

Hoogste 25 USD

Laagste 11 USD

Gebaseerd op 12 Wall Street-analisten die 12-maands prijsdoelen bieden voor NeoGenomics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

12 ratings

Buy

Hold

Sell

Gebaseerd op 12 analisten die aandelenratings hebben gegeven aan NeoGenomics Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

7.7 / 10.27Steun & Weerstand

Recent bearish events outweigh bullish events.

All events are bearish.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.